Reported Apr 30, 2014 · Terminated

Nicotine polacrilex lozenge, 2 mg, Mint Flavor, 81 count cartons and 189 count cartons. OTC. Labeled Nicorette,…

GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline · 65 Windham Blvd · Aiken, SC · 29805-9384

Is this the product you have?

  • Nicotine polacrilex lozenge, 2 mg, Mint Flavor, 81 count cartons and 189 count cartons. OTC. Labeled Nicorette
  • Distributed ByGlaxoSmithKline Consumer Healthcare, L.P., Moon Township, PA 15108. Made in Switzerland. 81
  • Count NDC
    • 0135-0510-05
    • 189
  • Count NDC0135-0510-03
Lot codes and dates
    • 81 Ct Vial
    • Lot # 13727 (exp 8/14)
    • 13816 (exp 10/14)
    • & 13965 (exp 12/14)
    • 189 Ct Vial
    • Lot # 12H17N (exp 4/14)
    • 12H20N (exp 6/14)
    • 12J16N (exp 6/14)
    • 12K03N (exp 9/14)
    • 12L05N (exp 10/14)
    • 12L07N (exp 9/14)
    • 12L17N (exp 10/14)
    • 13A04N (exp 11/14)
    • 13A23N (exp 11/14)
    • 13C04N (exp 1/15)
    • 13C08N (exp 1/15)
    • 13D17N (exp 11/14)
    • 13D18N (exp 1/15)
    • 13D18N1 (exp 3/15)
    • 13E24N (exp 4/15)
    • 13E28N (exp 4/15)
    • 13G16N (exp 4/15)
    • 13G17N (exp 5/14)
    • 13H02N (exp 5/15)
    • 13H22N (exp 5/15)
    • 13I18N (exp 8/15)
    • 13I20N (exp 5/15)
    • 13J24N (exp 8/15)
    • 13J24N1 (exp 9/15)
    • 13K08N (exp 8/15)
    • 13K11N (exp 9/15)
    • 13L11N (exp 10/15) & 13L11N1 (exp 10/15)
Amount recalled
147,684 81 Ct Vials, 130564 189 Ct Vials

This recall covers 10 products

The agency filed one notice per product. You are reading one of them; the other 9 are below.

Where it was sold

  • Nationwide

Why it was recalled

Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.

This product is unlikely to cause harm, but it breaks a safety or labelling rule.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new GlaxoSmithKline Consumer Healthcare;… recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Jan 20, 2017 · Data as of Sep 19, 8:05 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.